药物对比
Tirzepatide vs Miglitol
比较 Tirzepatide 与 Miglitol 治疗 2 型糖尿病。双重 GIP/GLP-1 激动剂（注射剂，A1C/体重降幅大）vs 口服α-葡萄糖苷酶抑制剂（胃肠道反应较轻）。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes weighing injectable dual-incretin therapy against an oral alpha-glucosidase inhibitor.
结论
Tirzepatide usually delivers superior glycemic and weight benefits, while Miglitol offers a convenient oral alternative with a distinct safety profile.
全部药物对比